ARWR Arrowhead Pharmaceuticals, Inc.

$81.72 +0.81%

Healthcare · Pharmaceutical Preparations

Arrowhead Pharmaceuticals, Inc. (ARWR) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $11.5 billion. Shares last traded at $81.72, 3.1% below their 52-week high. Over the past year the stock is up 427.1%. Net profit margin is -0.2%, below the peer median of -0.1%. Revenue grew 23258.2% year over year.

Market Cap

$11.5B

Shares Out

140.9M

EPS (TTM)

$1.18

P/E Ratio

69.26

P/S Ratio

13.88

P/B Ratio

18.75

Dividend / Share

—

Dividend Yield

—

52-Week High

$84.33

52-Week Low

$14.32

Volume

84,287

Avg Vol (3m)

89,919.079

Performance

+9.87%

+11.69%

+43.58%

+26.41%

YTD

+20.59%

+427.09%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

62.77

SMA (50)

$74.12

SMA (200)

$58.11

Price vs SMA50

+10.25%

Price vs SMA200

+40.65%

ATR (14)

$4.14

Financials

Revenue

$829M

Net Income

$-2M

Gross Margin

—

Operating Margin

11.9%

Net Margin

-0.2%

Return on Equity

-0.3%

Return on Assets

-0.1%

Current Ratio

6.23

Debt / Equity

—

Revenue Growth (YoY)

+23258.2%

Latest reported annual period ending 2025-09-30 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.73	2026-05-07
Q1 2026	$0.22	2026-02-05
FY 2025	$-0.01	2025-11-25
Q3 2025	$0.17	2025-08-07
Q2 2026	$1.52	2026-05-07
Q1 2026	$-1.39	2026-02-05

Full earnings history →

Pharmaceutical Preparations peers

ARWR vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

13.88 / 3.54 med

+292% premium

Net margin vs peers

-0.2% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.